Annual Retained Earnings
-$211.79 M
-$70.06 M-49.43%
December 31, 2022
Summary
- As of February 10, 2025, STSA annual retained earnings is -$211.79 million, with the most recent change of -$70.06 million (-49.43%) on December 31, 2022.
- During the last 3 years, STSA annual retained earnings has fallen by -$168.79 million (-392.53%).
Performance
STSA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$222.09 M
-$10.29 M-4.86%
March 31, 2023
Summary
- As of February 10, 2025, STSA quarterly retained earnings is -$222.09 million, with the most recent change of -$10.29 million (-4.86%) on March 31, 2023.
- Over the past year, STSA quarterly retained earnings has dropped by -$64.83 million (-41.23%).
Performance
STSA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
STSA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.4% | -41.2% |
| 3 y3 years | -392.5% | -305.5% |
| 5 y5 years | -2731.4% | - |
STSA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +49.4% | at low | +56.7% | at low |
| 5 y | 5-year | +392.5% | at low | +416.5% | at low |
| alltime | all time | +2731.4% | at low | +1397.9% | at low |
Satsuma Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$222.09 M(+4.9%) |
| Dec 2022 | -$211.79 M(+49.4%) | -$211.79 M(+12.3%) |
| Sep 2022 | - | -$188.66 M(+8.7%) |
| Jun 2022 | - | -$173.52 M(+10.3%) |
| Mar 2022 | - | -$157.25 M(+10.9%) |
| Dec 2021 | -$141.74 M(+56.5%) | -$141.74 M(+12.3%) |
| Sep 2021 | - | -$126.19 M(+11.8%) |
| Jun 2021 | - | -$112.85 M(+11.7%) |
| Mar 2021 | - | -$101.02 M(+11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | -$90.56 M(+110.6%) | -$90.56 M(+16.0%) |
| Sep 2020 | - | -$78.09 M(+18.2%) |
| Jun 2020 | - | -$66.04 M(+20.6%) |
| Mar 2020 | - | -$54.77 M(+27.4%) |
| Dec 2019 | -$43.00 M(+190.0%) | -$43.00 M(+33.6%) |
| Sep 2019 | - | -$32.19 M(+34.5%) |
| Jun 2019 | - | -$23.93 M(+61.4%) |
| Dec 2018 | -$14.83 M(+98.2%) | -$14.83 M |
| Dec 2017 | -$7.48 M | - |
FAQ
- What is Satsuma Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals annual retained earnings year-on-year change?
- What is Satsuma Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals quarterly retained earnings year-on-year change?
What is Satsuma Pharmaceuticals annual retained earnings?
The current annual retained earnings of STSA is -$211.79 M
What is the all time high annual retained earnings for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high annual retained earnings is -$7.48 M
What is Satsuma Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, STSA annual retained earnings has changed by -$70.06 M (-49.43%)
What is Satsuma Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of STSA is -$222.09 M
What is the all time high quarterly retained earnings for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high quarterly retained earnings is -$14.83 M
What is Satsuma Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, STSA quarterly retained earnings has changed by -$64.83 M (-41.23%)